Suppr超能文献

在患有肌少症、肥胖症和肌少症肥胖症的人群中,人类肋间肌中线粒体功能的恶化存在个体差异。

Deterioration of mitochondrial function in the human intercostal muscles differs among individuals with sarcopenia, obesity, and sarcopenic obesity.

机构信息

Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, College of Medicine, Gachon University, Incheon 21565, South Korea.

Department of Molecular Medicine, School of Medicine, Gachon University, Incheon 21999, South Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, South Korea; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon 21999, South Korea.

出版信息

Clin Nutr. 2021 May;40(5):2697-2706. doi: 10.1016/j.clnu.2021.03.009. Epub 2021 Mar 15.

Abstract

BACKGROUND & AIMS: Sarcopenic obesity (SO) increases the risk of mortality more than sarcopenia or obesity alone. Sarcopenia weakens the peripheral and respiratory muscles, leading to respiratory complications. It also induces mitochondrial dysfunction in the peripheral muscle; however, whether mitochondrial dysfunction in respiratory muscles differs among individuals with obesity, sarcopenia, and SO remains unknown. We evaluated the deterioration of respiratory muscle strength and mitochondrial function among normal, sarcopenia, obesity, and SO subjects.

METHODS

Twenty-five patients who underwent lung resections were enrolled between April 2017 and January 2021, and their intercostal muscles were harvested. Based on their L3 muscle index and visceral fat area, the patients were divided into four groups (normal, obesity, sarcopenia, and SO). The clinical data, mRNA expression, and protein expressions associated with mitochondrial biogenesis/fusion/fission in the intercostal muscles were compared among the four groups.

RESULTS

The respiratory muscle strength was evaluated using peak expiratory flow rate (PEFR). The PEFR values of the four groups were not significantly different. The levels of pAkt/Akt and mTOR (a marker of protein synthesis) were not significantly different among the four groups; however, those in the SO group were substantially lower than those in the sarcopenia or obesity groups. The levels of Atrogen-1 and MuRF1 (a marker of protein degradation) were not significantly different among the four groups; however, those in the SO group were substantially higher than those in the sarcopenia or obesity groups. Expression of PGC1-α (a marker of mitochondrial biogenesis) in the SO group was significantly lower than that in the normal group. MFN1 and MFN2 (marker of mitochondrial fusion) levels were significantly lower in the SO group than those in the normal group. DRP1 (a marker of mitochondrial fission) level in the SO group was substantially lower than that in the normal group. The expression of TNF-α (a pro-inflammatory cytokine) in the SO group was substantially lower than that in the normal group.

CONCLUSION

Our results suggest that the deterioration of protein synthesis and degradation of mitochondrial function in the respiratory muscles was most prominent in the SO before the weakening of the respiratory muscles. The deterioration mechanism may differentially regulate obesity, sarcopenia, and SO.

摘要

背景与目的

肌少症合并肥胖(SO)比单纯肌少症或肥胖导致死亡率增加的风险更高。肌少症削弱外周和呼吸肌,导致呼吸并发症。它还导致外周肌肉中线粒体功能障碍;然而,肥胖、肌少症和 SO 患者的呼吸肌线粒体功能障碍是否不同尚不清楚。我们评估了正常、肌少症、肥胖和 SO 患者的呼吸肌力量和线粒体功能的恶化情况。

方法

2017 年 4 月至 2021 年 1 月期间,我们招募了 25 名接受肺切除术的患者,并采集了他们的肋间肌。根据 L3 肌肉指数和内脏脂肪面积,患者被分为四组(正常、肥胖、肌少症和 SO)。比较了四组肋间肌中线粒体生物发生/融合/分裂相关的临床数据、mRNA 表达和蛋白表达。

结果

使用呼气峰流速(PEFR)评估呼吸肌力量。四组的 PEFR 值无显著差异。四组的 pAkt/Akt 和 mTOR(蛋白合成标志物)水平无显著差异;然而,SO 组的水平明显低于肌少症或肥胖组。四组的 Atrogen-1 和 MuRF1(蛋白降解标志物)水平无显著差异;然而,SO 组的水平明显高于肌少症或肥胖组。SO 组的 PGC1-α(线粒体生物发生标志物)表达明显低于正常组。SO 组的 MFN1 和 MFN2(线粒体融合标志物)水平明显低于正常组。SO 组的 DRP1(线粒体分裂标志物)水平明显低于正常组。SO 组的 TNF-α(促炎细胞因子)表达明显低于正常组。

结论

我们的结果表明,呼吸肌中线粒体功能的蛋白质合成和降解的恶化在呼吸肌减弱之前在 SO 中最为明显。恶化机制可能对肥胖、肌少症和 SO 进行不同的调节。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验